List of Contents

Home Healthcare Market Size, Share, and Trends 2024 to 2034

The global home healthcare market size was USD 373.56 billion in 2023, calculated at USD 423.97 billion in 2024 and is projected to surpass around USD 1,445.71 billion by 2034, expanding at a CAGR of 13.05% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 1190
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Home Healthcare Market 

5.1. COVID-19 Landscape: Home Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Home Healthcare Market, By Type

8.1. Home Healthcare Market, by Type, 2024-2034

8.1.1. Device

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Home Healthcare Market, By Device

9.1. Home Healthcare Market, by Device, 2024-2034

9.1.1. Diagnostic & Monitoring Devices

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Therapeutic Devices

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Home Mobility Assist Devices

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Home Healthcare Market, By Services 

10.1. Home Healthcare Market, by Services, 2024-2034

10.1.1. Rehabilitation

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Telehealth

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Respiratory Therapy

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Infusion Therapy

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Unskilled Homecare

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Home Healthcare Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Device (2021-2034)

11.1.3. Market Revenue and Forecast, by Services (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Services (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Device (2021-2034)

11.2.3. Market Revenue and Forecast, by Services (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Services (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Device (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Services (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Device (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Services (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Device (2021-2034)

11.3.3. Market Revenue and Forecast, by Services (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Services (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Device (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Services (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Device (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Services (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Services (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Device (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Services (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Device (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Services (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.5.3. Market Revenue and Forecast, by Services (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Device (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Services (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Device (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Services (2021-2034)

Chapter 12. Company Profiles

12.1. McKesson Medical-Surgical Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Fresenius Medical Care

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Becton, Dickinson And Company

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Arkray, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medline Industries, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. 3M Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Baxter International Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Medtronic PLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Braun Melsungen AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. ConvaTec Group PLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Molnlycke Health Care

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Acelity L.P.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

12.13. Hollister Inc.

12.13.1. Company Overview

12.13.2. Product Offerings

12.13.3. Financial Performance

12.13.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client